Recently in breast cancer, some naturally occurring alternative transcripts of BRCA1 and BRCA2, through mutational variants in the splicing sites, have been found to encode protein isoforms with residual tumor suppressive activity [13]. Here, BRCA2 is linked to neoplasm.